On Friday, Halozyme Therapeutics Inc (NASDAQ: HALO) opened lower -2.75% from the last session, before settling in for the closing price of $67.73. Price fluctuations for HALO have ranged from $41.28 to $70.50 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 39.83% annually for the last half of the decade. Company’s average yearly earnings per share was noted 26.57% at the time writing. With a float of $121.86 million, this company’s outstanding shares have now reached $123.17 million.
In an organization with 350 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 80.8%, operating margin of 54.32%, and the pretax margin is 54.87%.
Halozyme Therapeutics Inc (HALO) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Halozyme Therapeutics Inc is 1.10%, while institutional ownership is 99.77%. The most recent insider transaction that took place on Apr 28 ’25, was worth 271,467. In this transaction Director of this company sold 4,497 shares at a rate of $60.37, taking the stock ownership to the 28,611 shares. Before that another transaction happened on Apr 01 ’25, when Company’s Director sold 503 for $64.05, making the entire transaction worth $32,217. This insider now owns 33,108 shares in total.
Halozyme Therapeutics Inc (HALO) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 26.57% per share during the next fiscal year.
Halozyme Therapeutics Inc (NASDAQ: HALO) Trading Performance Indicators
Check out the current performance indicators for Halozyme Therapeutics Inc (HALO). In the past quarter, the stock posted a quick ratio of 7.30. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 7.49. Likewise, its price to free cash flow for the trailing twelve months is 16.37.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 3.77, a number that is poised to hit 1.21 in the next quarter and is forecasted to reach 7.16 in one year’s time.
Technical Analysis of Halozyme Therapeutics Inc (HALO)
Let’s dig in a bit further. During the last 5-days, its volume was 4.15 million. That was better than the volume of 1.59 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 78.63%. Additionally, its Average True Range was 2.93.
During the past 100 days, Halozyme Therapeutics Inc’s (HALO) raw stochastic average was set at 80.88%, which indicates a significant increase from 64.63% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 74.14% in the past 14 days, which was higher than the 39.02% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $61.42, while its 200-day Moving Average is $56.44. However, in the short run, Halozyme Therapeutics Inc’s stock first resistance to watch stands at $68.64. Second resistance stands at $71.42. The third major resistance level sits at $72.90. If the price goes on to break the first support level at $64.39, it is likely to go to the next support level at $62.91. The third support level lies at $60.13 if the price breaches the second support level.
Halozyme Therapeutics Inc (NASDAQ: HALO) Key Stats
There are currently 123,221K shares outstanding in the company with a market cap of 8.12 billion. Presently, the company’s annual sales total 1,015 M according to its annual income of 444,090 K. Last quarter, the company’s sales amounted to 298,010 K and its income totaled 137,010 K.
